[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Page 56965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20098]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Science 
Advisory Board for Biosecurity.
    The meeting will be held as a virtual meeting and is open to the 
public. Individuals who plan to view the virtual meeting and need 
special assistance or other reasonable accommodations to view the 
meeting should notify the Contact Person listed below in advance of the 
meeting. The meeting will be videocast and can be accessed from the NIH 
Videocasting and Podcasting website (http://videocast.nih.gov/).

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: September 21, 2022.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: The National Science Advisory Board for Biosecurity 
(NSABB) meeting will include a progress update from the NSABB 
Working Group to Review and Evaluate Potential Pandemic Pathogen 
Care and Oversight (PC3O) Policy, and stakeholder engagement on 
topics related to the U.S. Government policies for the Oversight of 
Dual Use Research of Concern (DURC).
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Suite 630, Bethesda, MD 20892, (Virtual Meeting Link will be 
available at https://osp.od.nih.gov/biotechnology/national-science-advisory-board-for-biosecurity-nsabb/#meetings).
    Contact Person: Cari Young, ScM, Acting Director, Division of 
Biosafety, Biosecurity, and Emerging Biotechnology Policy, Office of 
Science Policy, Office of the Director, National Institutes of 
Health, 6705 Rockledge Drive, Suite 630, Bethesda, MD 20892, (301) 
594-3746, [email protected].

    To sign up to make an oral public comment at the meeting, please 
send an email to the Contact Person listed above at least one 
business day prior to the meeting date. Once all time slots are 
filled, only written comments will be accepted. Any interested 
person may file written comments by forwarding the statement to the 
Contact Person listed on this notice at least one business day prior 
to the meeting date. The statement should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person. Other than name and contact 
information, please do not include any personally identifiable 
information or any information that you do not wish to make public. 
Proprietary, classified, confidential, or sensitive information 
should not be included in your comments. Please note that any 
written comments NIH receives may be posted unredacted to the Office 
of Science Policy website.
    Information is also available on the NIH Office of Science 
Policy website: https://osp.od.nih.gov/biotechnology/national-science-advisory-board-for-biosecurity-nsabb/#meetings, where an 
agenda, link to the webcast meeting, and any additional information 
for the meeting will be posted when available. Materials for this 
meeting will be posted prior to the meeting. Please check this 
website for updates.
    This notice is being published less than 15 days prior to the 
meeting due to scheduling difficulties.

    Dated: September 13, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-20098 Filed 9-15-22; 8:45 am]
BILLING CODE 4140-01-P